Sanofi US

Sanofi US We’re an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. For U.S. residents only. FOR U.S.

https://www.sanofi.com/en/chasing-miracles RESIDENTS ONLY. Interactions with our Sanofi US page must comply with our terms: http://bit.ly/US-terms. This page is intended to provide a forum for discussions regarding Sanofi US. If treatments are discussed, we can only allow messages that are in accordance with the FDA approved use. This page is not intended as a forum for reporting Sanofi US or other company's products' side effects associated with the use of prescription drugs. For more information on our products, please visit https://www.sanofi.us/en/products-and-resources. For questions relating to our products or treatments, please visit https://www.sanofi.us/en/contact-us. MAT-US-2510212-v1.0-09/2025

02/12/2026

Better health starts in our communities.

With our Healthy Futures Solution Fund, we're making a multi-year commitment to empower community-led solutions and build meaningful partnerships in historically under-supported areas.

Together, we're driving long-term change by tackling root causes and creating lasting impact.

02/11/2026

Xavier is re-writing the script on what life can look like with autoimmune type 1 diabetes (T1D), so that people with T1D can be the star of their own story.

02/03/2026

From athletics to the arts, Xavier is now a writer and filmmaker, inspiring others to live authentically. His story proves chronic illness doesn't diminish ambition!

We’re chasing the miracles so people like Xavier can continue to chase their dreams.

01/28/2026

Xavier is chasing his dream of becoming a filmmaker and advocate, determined to bring diabetes representation to the screen.

Keep chasing, Xavier. We’re right beside you.

Type 1 diabetes (T1D) changed Xavier's life, but it didn’t limit his dreams — it redefined them! 🎬We’re leading a new er...
01/21/2026

Type 1 diabetes (T1D) changed Xavier's life, but it didn’t limit his dreams — it redefined them! 🎬

We’re leading a new era in T1D care, chasing the miracles of science so people like Xavier can continue to chase their dreams.

01/14/2026

Meet Xavier, a talented artist and performer who shares his inspiring journey of living with type 1 diabetes (T1D) since age 18.

From navigating the challenges of his diagnosis and managing his health to pursuing his passion for the arts and advocating for others with T1D, Xavier embodies the power of chasing dreams.

Respiratory syncytial virus (RSV) is too important to stay behind the scenes. That’s why we took the conversation to a n...
12/23/2025

Respiratory syncytial virus (RSV) is too important to stay behind the scenes. That’s why we took the conversation to a national stage—The Jennifer Hudson Show! 🎤✨

Joined by a celebrity mom and a pediatrician, we shared how parents can help protect their little ones from serious RSV lung infection.

✅ Did you know? While most RSV cases are mild, serious RSV lung infection is a leading cause of hospitalization in babies under 1. With RSV season lasting from fall into spring in the majority of the US now is the time to act.

👉 Talk to your baby’s doctor today and learn how to help protect them against serious RSV lung infection.

📺 Catch the full conversation here: http://spkl.io/6180AYTlo

12/12/2025

What does stability in (MS) really mean? Relapses, MRI activity, and cognitive and physical abilities must all be under control for MS to truly be considered stable.

Rediscover a more complete picture of MS and browse helpful resources. ➡️ http://spkl.io/6182AiPF8

12/11/2025

For most of the US, as temperatures drop, respiratory syncytial virus (RSV) cases typically rise — and it can be more than just a cold. In fact, RSV lung infection is a leading cause of hospitalization in babies under 1, although most cases are mild.

Hear real stories from parents who faced RSV with their babies and learn why it’s important to prioritize protection for yours by clicking below.

Don’t wait — RSV season is now. Talk to your baby’s doctor about how to help protect your little ones from this highly contagious virus.

12/08/2025

When we champion inclusion for all, the happiness is real ✨

We’re proud of our Employee Business Resource Groups (EBRGs) and Affinity Groups (AGs) for creating a workplace where everyone can be their true selves 💪

At 17, John received an immune thrombocytopenia (ITP) diagnosis that changed his academic experience and taught him the ...
11/25/2025

At 17, John received an immune thrombocytopenia (ITP) diagnosis that changed his academic experience and taught him the importance of advocacy. Through connecting with patients and advocates in the ITP community, John discovered his voice could help shape research and support others on their own journeys. Learn more about the power of self-advocacy within the ITP community: http://spkl.io/6181Aellf

11/25/2025

When Andrew, co-lead of our US CareGive Affinity Group, unexpectedly stepped into a caregiving role for his mom, he discovered strength through community.

We're proud of Affinity Groups like CareGive—creating spaces where employees can find resources, understanding, and support during some of life's most challenging moments.

Address

Morristown, NJ

Website

https://www.linkedin.com/company/sanofi/, https://www.sanofi.com/en/chasing-miracles

Alerts

Be the first to know and let us send you an email when Sanofi US posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sanofi US:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Terms of Use The Sanofi US Facebook timeline is open to your comments. We welcome engaging in a dialogue with you, but please note that we operate in a regulated industry. In this highly regulated environment the Company has chosen to remove certain posts. This page is intended to provide a forum for discussions regarding Sanofi US. If treatments are discussed, we can only allow messages that are in accordance with the FDA approved use. This page is not intended as a forum for reporting Sanofi US or other company's products' side effects associated with the use of prescription drugs. If comments include possible adverse events or side effects associated with any product, Sanofi US may be required to contact you for further information, per the company's Adverse Events Reporting Guidelines. Sanofi US is not responsible for the postings and opinions of third parties. Sanofi US does not verify, approve or endorse the comments or any information posted by visitors to this page, does not warrant their accuracy, and assumes no responsibility or liability arising from content of the page nor for any error, omission, defamation, libel, or slander. Caution should be used before relying on any particular statements or opinions expressed herein. Please visit http://www.sanofi.us/l/us/en/layout.jsp?scat=8D4FB6C0-9DD0-4C74-8C94-9859D8B2687B for information on Sanofi US products. For product-related or other questions, please visit http://contactus.sanofi.us/default.aspx to contact the appropriate Sanofi US department. If you, or someone you know, have possibly experienced a side effect while taking any Sanofi US product, please contact our Drug Safety Department at 1-800-633-1610, option 2, or via fax at 1-908-203-7783. You are also encouraged to report side effects of prescription drugs to the FDA. To do so, visit www.fda.gov/medwatch or call 1-800-FDA-1088. We reserve the right to block users from this page who violate the Terms of Use. We reserve the right to remove this page and its contents at any time. Please check often for updates, as we reserve the right, in our sole discretion, to modify these Terms of Use at any time. Your use of this page indicates your acceptance of any revisions to these terms.